DOMH · Dominari Holdings Inc. · Insider Trading

On July 27, 2026, the Reporting Person made a charitable gift of 250,000 shares to Hayes Charitable Foundation. No value was received for the gifted shares.

On July 1, 2026, the Reporting Person was granted stock options to purchase 20,000 shares of common stock of Dominari Holding Inc. pursuant to the 2022 Equity Incentive Plan. The granted stock options are exercisable on July 1, 2027.

On July 1, 2026, the Reporting Person was granted stock options to purchase 20,000 shares of common stock of Dominari Holding Inc. pursuant to the 2022 Equity Incentive Plan. The granted stock options are exercisable on July 1, 2027.

On July 1, 2026, the Reporting Person was granted stock options to purchase 20,000 shares of common stock of Dominari Holding Inc. pursuant to the 2022 Equity Incentive Plan. The granted stock options are exercisable on July 1, 2027.

On July 1, 2026, the Reporting Person was granted stock options to purchase 20,000 shares of common stock of Dominari Holding Inc. pursuant to the 2022 Equity Incentive Plan. The granted stock options are exercisable on July 1, 2027.

On July 1, 2026, the Reporting Person was granted stock options to purchase 20,000 shares of common stock of Dominari Holding Inc. pursuant to the 2022 Equity Incentive Plan. The granted stock options are exercisable on July 1, 2027.

On January 7, 2026, the Reporting Person was granted 3,000,000 shares of common stock pursuant to the 2022 Equity Incentive Plan. The grant was originally subject to stockholder approval of an amendment to the 2022 Equity Incentive Plan, which was obtained on March 4, 2026, and registration of the shares on Form S-8, which occurred on March 13, 2026. On March 18, 2026, the shares were issued to Reporting Person.

On January 7, 2026, the Reporting Person was granted 3,000,000 shares of common stock pursuant to the 2022 Equity Incentive Plan. The grant was originally subject to stockholder approval of an amendment to the 2022 Equity Incentive Plan, which was obtained on March 4, 2026, and registration of the shares on Form S-8, which occurred on March 13, 2026. On March 18, 2026, the shares were issued to Reporting Person.

On January 9, 2026, the Reporting Person was granted 25,000 shares of restricted stock pursuant to the 2022 Equity Incentive Plan. The granted shares vested on January 9, 2026.

On January 9, 2026, the Reporting Person was granted 25,000 shares of restricted stock pursuant to the 2022 Equity Incentive Plan. The granted shares vested on January 9, 2026.

On January 9, 2026, the Reporting Person was granted 25,000 shares of restricted stock pursuant to the 2022 Equity Incentive Plan. The granted shares vested on January 9, 2026.

On January 9, 2026, the Reporting Person was granted 316,346 shares of restricted stock pursuant to the 2022 Equity Incentive Plan. The granted shares will vest upon the earlier of 1) September 30, 2026, or 2) an Acceleration Event has occurred ("Acceleration Event" means the occurrence of any of the following: (i) a Change in Control (as defined in the 2022 Equity Incentive Plan); (ii) a termination of the Reporting Person's services by the Company other than for Cause (as defined in the 2022 Equity Incentive Plan); (iii) a termination of the Reporting Person's services by the Reporting Person for Good Reason; or (iv) a termination of the Reporting Person's services as a result of the Reporting Person's death or total disability, as determined by the 2022 Equity Incentive Plan administrator).

On December 11, 2025, the Reporting Person was granted 10,000 shares of restricted stock pursuant to the 2022 Equity Incentive Plan, by and between the Reporting Person and the Issuer. The granted shares will vest on 12/11/2026.

This amendment is being filed to correct an inadvertent typographical error in Table I original Form 4, filed December 10, 2025, in which the Ownership Form Codes were incorrectly listed as "Disposed Of" (D), rather than "Securities Acquired" (A). This amendment corrects such details in Table I to reflect the acquisition of securities.

This amendment is being filed to correct an inadvertent typographical error in Table I original Form 4, filed December 10, 2025, in which the Ownership Form Codes were incorrectly listed as "Disposed Of" (D), rather than "Securities Acquired" (A). This amendment corrects such details in Table I to reflect the acquisition of securities.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 to $3.92. The Reporting Person undertakes to provide to the Issuer, any security holders of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within this range. The shares were sold primarily for purposes of satisfying tax obligations related to the grant of 351,851 shares of the Issuer's common stock to the Reporting Person on February 10, 2025.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $4.17. The Reporting Person undertakes to provide to the Issuer, any security holders of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within this range. The shares were sold primarily for purposes of satisfying tax obligations related to the grant of 351,851 shares of the Issuer's common stock to the Reporting Person on February 10, 2025.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.15 to $4.27. The Reporting Person undertakes to provide to the Issuer, any security holders of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within this range. The shares were sold primarily for purposes of satisfying tax obligations related to the grant of 351,851 shares of the Issuer's common stock to the Reporting Person on February 10, 2025.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.10 to $4.30. The Reporting Person undertakes to provide to the Issuer, any security holders of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within this range. The shares were sold primarily for purposes of satisfying tax obligations related to the grant of 351,851 shares of the Issuer's common stock to the Reporting Person on February 10, 2025.

On September 23, 2025, the Reporting Person sold 14,409 shares of the Issuer's common stock, at an average offering price of $7.99 per share.

On May 5, 2025, the Reporting Person made a charitable gift of 15,000 shares. No value was received for the gifted shares.

On April 16, 2025, the Reporting Person accepted a stock option to purchase 5,000,000 shares of the Issuer's Common Stock by the Compensation Committee of the Issuer's board of directors under the Issuer's 2022 Equity Incentive Plan, which are exercisable upon the filing of a Form S-8 to register the shares of Common Stock subject to the stock option, and have an exercise price of $6.16 and expire February 9, 2035.

On April 16, 2025, the Reporting Person accepted a stock option to purchase 5,000,000 shares of the Issuer's Common Stock by the Compensation Committee of the Issuer's board of directors under the Issuer's 2022 Equity Incentive Plan, which are exercisable upon the filing of a Form S-8 to register the shares of Common Stock subject to the stock option, and have an exercise price of $6.16 and expire February 9, 2035.

On March 24, 2025, the Reporting Person was granted 154,559 shares of the Issuer's common stock by the Compensation Committee of the Issuer's board of directors.

On February 18, 2025, the Reporting Person was issued an aggregate of 150,000 shares of restricted stock pursuant to the Advisory Board Agreement, by and between the Reporting Person and the Issuer.

On February 18, 2025, the Reporting Person was issued an aggregate of 150,000 shares of restricted stock pursuant to the Advisory Board Agreement, by and between the Reporting Person and the Issuer.

On February 18, 2025, the Reporting Person was granted 500,000 shares of the Issuer's common stock by the Compensation Committee of the Issuer's board of directors.

On February 10, 2025, Kyle Wool was purchased 288,184 shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

Of the 2,200,769 shares reported as beneficially owned directly, 958,780 shares are beneficially owned directly by Mr. Wool and 1,241,989 shares are beneficially owned directly by Ms. Yu.

On March 24, 2025, Mr. Wool was granted 154,559 shares of the Issuer's common stock by the Compensation Committee of the Issuer's board of directors.

Of the 2,355,328 shares reported as beneficially owned directly, 1,113,339 shares are beneficially owned directly by Mr. Wool and 1,241,989 shares are beneficially owned directly by Ms. Yu.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person was granted 10,000 shares of restricted stock at $3.22 per share pursuant to the Company's 2022 Equity Incentive Plan.

On February 10, 2025, the Reporting Person was granted 10,000 shares of restricted stock at $3.22 per share pursuant to the Company's 2022 Equity Incentive Plan.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reported Person was granted 351,851 shares of the Issuer's common stock by the Compensation Committee of the Issuer's board of directors.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person was granted 10,000 shares of restricted stock at $3.22 per share pursuant to the Company's 2022 Equity Incentive Plan.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person was granted 10,000 shares of restricted stock at $3.22 per share pursuant to the Company's 2022 Equity Incentive Plan.

On February 10, 2025, Kyle Wool was purchased 288,184 shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.

On February 10, 2025, the Reporting Person purchased shares of the Issuer's common stock together with Series A Warrants and Series B Warrants in the Issuer's private placement offering which closed on February 12, 2025, at a combined offering price of $3.47.